Sahlsten Hanna, Virtanen Juuso, Joutsa Juho, Niinivirta-Joutsa Katri, Löyttyniemi Eliisa, Johansson Reijo, Paavola Janika, Taiminen Tero, Sjösten Noora, Salonen Jaakko, Holm Anu, Rauhala Esa, Jääskeläinen Satu K
a Faculty of Medicine , University of Turku , Turku , Finland.
b Department of Clinical Neurophysiology , Turku University Hospital and University of Turku , Turku , Finland.
Int J Audiol. 2017 Sep;56(9):692-700. doi: 10.1080/14992027.2017.1313461. Epub 2017 Apr 18.
Repetitive transcranial magnetic stimulation (rTMS) may alleviate tinnitus. We evaluated effects of electric field (E-field) navigated rTMS targeted according to tinnitus pitch. No controlled studies have investigated anatomically accurate E-field-rTMS for tinnitus.
Effects of E-field-rTMS were evaluated in a prospective randomised placebo-controlled 6-month follow-up study on parallel groups. Patients received 10 sessions of 1 Hz rTMS or placebo targeted to the left auditory cortex corresponding to tonotopic representation of tinnitus pitch. Effects were evaluated immediately after treatment and at 1, 3 and 6 months. Primary outcome measures were visual analogue scores (VAS 0-100) for tinnitus intensity, annoyance and distress, and the Tinnitus Handicap Inventory (THI).
Thirty-nine patients (mean age 50.3 years).
The mean tinnitus intensity (F = 15.7, p < 0.0001), annoyance (F = 8.8, p = 0.0002), distress (F = 9.1, p = 0.0002) and THI scores (F = 13.8, p < 0.0001) decreased in both groups over time with non-significant differences between the groups. After active rTMS, 42% and 37% of the patients showed excellent response at 1 and 3 months against 15% and 10% in the placebo group (p = 0.082 and p = 0.065).
Despite the significant effects of rTMS on tinnitus, differences between active and placebo groups remained non-significant, due to large placebo-effect and wide inter-individual variation.
重复经颅磁刺激(rTMS)可能会减轻耳鸣。我们评估了根据耳鸣音调进行电场(E场)导航的rTMS的效果。尚无对照研究调查用于耳鸣的解剖学精确的E场-rTMS。
在一项前瞻性随机安慰剂对照的平行组6个月随访研究中评估E场-rTMS的效果。患者接受10次针对与耳鸣音调的音调定位相对应的左侧听觉皮层的1Hz rTMS或安慰剂治疗。在治疗后立即以及在1、3和6个月时评估效果。主要结局指标是耳鸣强度、烦恼和痛苦的视觉模拟评分(VAS 0-100)以及耳鸣障碍量表(THI)。
39名患者(平均年龄50.3岁)。
随着时间的推移,两组的平均耳鸣强度(F = 15.7,p < 0.0001)、烦恼(F = 8.8,p = 0.0002)、痛苦(F = 9.1,p = 0.0002)和THI评分(F = 13.8,p < 0.0001)均下降,两组之间差异无统计学意义。在进行主动rTMS后,42%和37%的患者在1个月和3个月时显示出极佳反应,而安慰剂组分别为15%和10%(p = 0.082和p = 0.065)。
尽管rTMS对耳鸣有显著影响,但由于安慰剂效应大且个体间差异大,主动治疗组与安慰剂组之间的差异仍无统计学意义。